Безопасен ли heptapeptide-46 при беременности?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment addressing reproductive or developmental effects, and no peer-reviewed reproductive toxicity data located for 'heptapeptide-46'. Under the default/CIR calibration, absence of evidence of reproductive hazard = h=0. Topical cosmetic peptides are generally large and have low dermal absorption absent specific permeation data, so exposure is considered negligible for pregnancy (e=0). No known reproductive mechanism identified (m=0). Sources searched: ECHA C&L/Annex VI, SCCS/CIR databases, PubMed, PubChem, CosIng, EWG.
Related ingredients
Frequently asked questions
- Безопасен ли heptapeptide-46 при беременности?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment addressing reproductive or developmental effects, and no peer-reviewed reproductive toxicity data located for 'heptapeptide-46'. Under the default/CIR calibration, absence of evidence of reproductive hazard = h=0. Topical cosmetic peptides are generally large and have low dermal absorption absent specific permeation data, so exposure is considered negligible for pregnancy (e=0). No known reproductive mechanism identified (m=0). Sources searched: ECHA C&L/Annex VI, SCCS/CIR databases, PubMed, PubChem, CosIng, EWG.
- Безопасен ли heptapeptide-46 при грудном вскармливании?
- No data identified indicating a hazard to lactation or breastfed infants; no harmonised classification or regulatory safety concerns located. Without evidence of systemic absorption or mammary transfer, exposure is considered negligible for breastfeeding (e=0). No known mechanism for reproductive or developmental toxicity (m=0).
- Безопасен ли heptapeptide-46 для кожи малыша?
- No infant-specific toxicity or absorption data found. Default hazard and mechanism scores remain 0. Exposure score increased by +1 vs adult (to e=1) because infant skin has higher surface-area-to-weight and an immature barrier, so any ingredient with potential for measurable absorption is conservatively given a small increase in exposure in absence of specific dermal absorption data. No evidence of specific risk to 0–3 year skin was identified in the searched sources.
- Как VeriMom оценивает heptapeptide-46?
- VeriMom оценивает heptapeptide-46 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы heptapeptide-46 при беременности?
- См. наш список безопасных альтернатив heptapeptide-46 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.